My research is mainly focused on developing leading-edge mass spectrometry-based proteomics technologies and applying them to 1) elucidate the molecular mechanisms of cancer progression and metastasis, 2) identify and credential clinically actionable therapeutic targets for precision treatment of lethal cancer, and 3) discover novel biomarkers to select patients and monitor drug response.

• Doctorate: Peking University, 2006

View CV as a PDF

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Urologic Oncology
• Department of Surgery
• Cancer
• Surgery

Click here for a list of peer-reviewed publications.

• Zhou B, An M, Freeman MR, Yang W. Technologies and challenges in proteomic analysis of protein S-acylation. J Proteomics Bioinform. 2014;7(9):256-263.
• Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles
• Quantitative proteomic analysis of prostate tissue specimens identifies deregulated protein complexes in primary prostate cancer